Partners Elvira Aliende Rodriguez and Geert Goeteyn (both Brussels-Antitrust) were quoted in a Global Competition Review article titled “Cartelist cannot jump on annulment train, rules EU court” on May 8, following the General Court’s judgment in Lucchini.
Partners Ben Gris, David Higbee, Djordje Petkoski and associate Mark Weiss (all Washington, D.C.-Antitrust) authored the article “The Department of Defense’s Role in Merger Review” for the April edition of Competition Policy International’s Antitrust Chronicle. The article provides an overview of the organization and leadership of the Office of Industrial Policy and discusses its involvement in the antitrust review process.
Partner Ben Gris and associate Mark G. Weiss (both Washington, D.C. – Antitrust) authored an article in The M&A Lawyer titled “The FTC’s Consent Decree in the Staples/Essendant Deal Sets the Playing Field for the New Commission’s Split on Antitrust Enforcement.” The article notes that the length and depth of the review shows that the FTC is quite active and thorough, even when investigating vertical deals.
Partner Elvira Aliende Rodriguez (Brussels-Antitrust) was quoted by Global Competition Review in the article “EU fines Nike for vertical restraints” that was published on March 25 after the European Commission published their press release that they fined Nike for restricting cross-border sales of merchandising products.
Partner James Webber (London-Antitrust) was quoted in Global Competition Review’s article on his insights around the Competition and Markets Authority (CMA) review process for companies pursuing a merger.
Of Counsel Simon Dodds (London-Financial Institutions Advisory & Financial Regulatory) discusses how to build the best relationships between in-house counsel and law firms with Craft Counsel.
Partner Elvira Aliende Rodriguez (Brussels-Antitrust) authored the article “Hybrid Settlement Cases Post-ICAP: Potential Changes to the Scope of Future EC Procedures,” with the assistance of associates Ruba Noorali (London-Antitrust) and Agostino Bignardi (Brussels-Antitrust). The article was published by Competition Law Insight in January 2019
The U.S. Federal Trade Commission (FTC) has revised, and once again raised, the thresholds for the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”).
Associate Mark Weiss (Antitrust-Washington, DC), writing for the American Bar Association’s Cartel & Joint Conduct Review Winter 2019 edition, analyzes the Seventh Circuit Court of Appeals decision to affirm a lower court’s dismissal of a putative class action by indirect purchaser plaintiffs alleging that seven U.S. steel producers conspired to fix prices on the sale of steel products in the United States.
On Thursday, 7th February, the Judiciary Committee of the U.S. House of Representatives approved the No Producing and Exporting Cartels Act 2019 (NOPEC), potentially setting up a vote by the full House. NOPEC was followed by similar bill, introduced in the Senate by Republican Senator Chuck Grassley (who is a strong supporter of the U.S. ethanol and biofuel industries). This bill has picked up support from senators in both parties.
Partner Geert Goeteyn (Brussels-Antitrust) has co-authored the article “The Italian Unilever Judgment on Exclusive Dealing: Helpful Clarification or Misguided Limitation of the Court of Justice’s Intel Ruling?”
The long-awaited judgment of the General Court (GC) in the pay-TV saga (case AT.40023 Cross-border access to pay-TV) has finally been delivered, two years after the annulment action was brought.
A senior executive of a public company has agreed to pay $609,810 in civil penalties for acquiring additional voting securities in the company without first making a Hart-Scott-Rodino Act filing and observing the statutory waiting period.
Associate Timothy Slattery (Antitrust-Washington, DC) has contributed to the Pharmaceutical Industry Antitrust Handbook (2nd Ed.) published by the American Bar Association.
Senior associate Timothy Slattery (Washington, D.C.-Antitrust) has authored the article “Sample Shaming: FDA’s Open Letter on Access to Samples Under REMS Programs Publically Calls Out Branded Drug Manufacturers to Aid Generic Entry” in Antitrust Advisors, a publication of the American Health Lawyers Association Antitrust Practice Group. The article was published in September 2018.
Partners Matthew Readings (London-Antitrust), Elvira Aliende Rodriguez and Geert Goeteyn (both Brussels-Antitrust); counsel Paolisa Nebbia (Rome/ Milan-Antitrust) and Mathias Stöcker (Frankfurt-Antitrust); and associate Ruba Noorali authored various chapters of the International Comparative Legal Guide to: Cartels & Leniency 2019.
Partners Jessica Delbaum (New York-Antitrust) and David Higbee (Washington, D.C.-Antitrust) co-authored the chapter “United States” for IP & Antitrust Know-How 2018” published by Global Competition Review.